Twitter LinkedIn
    Saturday, July 2
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Carlyle, Hikaru Shimura to Acquire 100% Stake in Japan’s X-ray Technology Company Rigaku
    Deals & Transactions

    Carlyle, Hikaru Shimura to Acquire 100% Stake in Japan’s X-ray Technology Company Rigaku

    January 9, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Carlyle, with USD 230bn in total AUM, plans to expand the reach of the X-ray technology company at the global level and prepare it for an IPO.

    The Carlyle Group Inc, a Washington-based global investment firm, along with Hikaru Shimura, President and CEO of Rigaku Corp, a Tokyo-based specialized in X-ray related technologies company, agreed to acquire a 100% stake in Rigaku.

    The parties didn’t disclose the financial terms of the transaction. Carlyle is investing on behalf of its Carlyle Japan Partners IV fund.

    Carlyle and Mr. Shimura will own the Japnese company through a newly formed holding company in which Carlyle will hold c. 80% stake, while Mr. Shimura will own the remaining stake.

    Carlyle, with USD 230bn in total AUM, plans to expand the reach of the X-ray technology company at the global level and prepare it for an IPO.

    “Under the leadership of Mr. Shimura, Rigaku has grown into a leading global player with superior technology, a solid and diversified customer base, and highly competitive R&D and manufacturing capabilities. It is an honor that he has chosen Carlyle as the partner to take Rigaku into its next phase by building a robust global organization under a new management team,” said Takaomi Tomioka, Deputy Head of Carlyle Japan.

    In November last year, AnalayzeMarkets reported that Caryle is in advanced negotiations to acquire Granules India Ltd, a Hyderabad, India-based pharmaceutical company.

    Carlyle Is Said in Talks to Acquire USD 1.4bn Indian Listed Pharmaceutical Granules

    Founded in 1951, Rigaku is an international manufacturer and distributor of general X-ray diffraction products.

    With a diversified customer base of over 10,000 customers globally, Rigaku is engaged in the field of X-ray analysis, measurement, and testing instruments. Its products analyze the composition and structure of various materials, and are used in a wide range of science and technology applications, including state-of-the-art R&D and production.

    It has an annual revenue of JPY 44bn (c. USD 428mn), out of which around two-thirds is generated outside of Japan.

    Source: AnalyzeMarkets

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Acquisitions Buyouts deals Investments Transactions
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Carlyle hires BlackRock’s McNeely to work with biggest clients

    July 1, 2022

    Permira considers sale of Funds Platform Alter Domus

    July 1, 2022

    Clearlake Capital explores sale of Team Technologies for more than $1B

    July 1, 2022

    TVS Motor in talks with TPG Capital and KKR to raise $300m for EV business

    June 30, 2022

    Comments are closed.

    Other Articles

    Ironwood Capital makes subordinated debt and equity investment in ALCOM

    January 7, 2021

    Transact pulls out of race to buy Nucleus

    January 5, 2021

    Partners Group to acquire Axia Women’s Health

    May 5, 2021

    China’s HLC, Panacea lead $100m funding in biotech startup Inmagene

    June 1, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2022 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.

    Lost password?